← Back to Search

Recast Therapy vs. Book Reading for Developmental Language Disorder

N/A
Recruiting
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primarily English speaking as documented by 20% or less exposure to another language, per parent report on the MAPLE
Diagnosed with DLD as documented by standard score below 85 on the Diagnostic Evaluation of Language Variation - Norm Referenced (DELV-NR) composite
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks post therapy ( ~12- 14 week mark in study timeline)
Awards & highlights

Study Summary

This trial will examine alternative methods of delivering treatment for Developmental Language Disorder (DLD) in order to identify implementation barriers and improve long-term outcomes.

Who is the study for?
This trial is for children aged 4-9 with Developmental Language Disorder (DLD), primarily English-speaking, and without autism or significant sensory-motor or psychiatric disorders. They must have a DLD diagnosis confirmed by specific language tests, hearing within the typical range, and caregivers willing to participate in training.Check my eligibility
What is being tested?
The study is testing two treatments for DLD: Recast Therapy where clinicians repeat children's phrases with grammatical improvements, and Syntax Stories which involves reading specially designed stories to improve grammar. The goal is to find feasible methods that can be used in typical service conditions.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves speech therapy techniques rather than medication. However, there may be varying levels of engagement or stress associated with the different treatment approaches.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I mainly speak English, with little exposure to other languages.
Select...
My language skills were scored below 85 on the DELV-NR test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks post therapy ( ~12- 14 week mark in study timeline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 weeks post therapy ( ~12- 14 week mark in study timeline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Accuracy on Elicited Production Probes
Change in Comprehension probes (Proportion Looking)
Estimated Dose Delivered
+1 more
Secondary outcome measures
Caregiver grammar knowledge
Change in Comprehension probes (Pointing)
Effortfulness of treatment
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Recast Therapy Provided by a CaregiverExperimental Treatment1 Intervention
Caregivers will receive two training sessions on how to provide recast therapy and demonstrate their skill at providing recast therapy with support from the clinician. Caregivers will then provide recast therapy at a rate of 1 recast per minute to their children for a minimum of 16 hrs (960 exposures) scheduled at their own convenience.
Group II: Recast Therapy Provided By ClinicianExperimental Treatment1 Intervention
Children will be exposed to recasts at a rate of 1/minute. Treatment will be provided 2x/week for 8 weeks for a total of 16 visits (960 recasts). 2 additional weeks are allocated for make up visits. Treatment will be provided by a trained, certified, licensed Speech Language Pathologist (SLP).
Group III: Illustrated Syntax Stories Provided by a CaregiverExperimental Treatment1 Intervention
Caregivers will receive two training sessions on how to provide read illustrated syntax stories to their children and demonstrate their skill at reading these stories with support from the clinician. Caregivers will then read these stories to their children for a minimum of 32 book readings (960 exposures)
Group IV: Illustrated Syntax Stories Provided by ClinicianExperimental Treatment1 Intervention
Children will be listen to books that are specially scripted to promote the use of a particular syntax target. Treatment will be provided 2x/week for 8 weeks for a total of 16 visits (960 exposures), with 2 books read at each visit. 2 additional weeks are allocated for make up visits. Treatment will be provided by a trained, certified, licensed SLP.

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,051 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,311 Total Patients Enrolled
University of Maryland, College ParkOTHER
155 Previous Clinical Trials
45,505 Total Patients Enrolled

Media Library

Recast Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05099328 — N/A
Developmental Language Disorder Research Study Groups: Recast Therapy Provided By Clinician, Illustrated Syntax Stories Provided by Clinician, Recast Therapy Provided by a Caregiver, Illustrated Syntax Stories Provided by a Caregiver
Developmental Language Disorder Clinical Trial 2023: Recast Therapy Highlights & Side Effects. Trial Name: NCT05099328 — N/A
Recast Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05099328 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who can be considered an eligible participant for this trial?

"This clinical trial seeks 160 participants with speech delay, aged between 4 and 9. Acceptance is contingent upon these criteria being fulfilled."

Answered by AI

Are there vacancies within this clinical trial for participants?

"According to the clinicaltrials.gov database, this research endeavour initiated on September 28th 2021 and was last modified on November 1st 2022 is currently seeking patient participation."

Answered by AI

What is the current population size for this research project?

"Affirmative. According to information on clinicaltrials.gov, this medical experiment is still searching for volunteers and was initially posted on September 28th 2021 with an updated version released November 1st 2022. 160 participants are required from 2 sites in order to complete the study."

Answered by AI

What are the prime goals of this experiment?

"The main objective of this 10-week clinical trial is to carry out semi-structured interviews with its participants. Additionally, the Theoretical Domains Framework (TDF) Questionnaire will be employed to assess caregivers' understanding and determination for involvement in treatment. Moreover, Change in Comprehension probes (Pointing) tasks involving 24 items each regarding treated target and control structure are set up; points allocated to correct pictures after eye gaze collection completion serve as dependent variables. Last but not least, Effortfulness of treatment will be estimated via Likert ratings given by healthcare professionals delivering therapy."

Answered by AI

Is eligibility for this research restricted to individuals aged 60 or older?

"This medical study is meant to target children aged 4 to 9. There are 27 trials that accept participants under 18 years of age and another 6 for those above the pensionable period."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Recasting or Book Reading by Parents or Clinicians
Amanda J. Owen Van Horne 2021. "Recasting or Book Reading by Parents or Clinicians". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05099328.
~74 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top